BASF ends pursuit of Evonik after two offers rejected
BASF SE (BASFn) ended its pursuit of Evonik Industries AG after two offers were rejected. BASF proposed 24 euros per share, but Evonik deemed it not in shareholders' best interests. BASF cited valuation concerns and lack of engagement from Evonik's board. The decision aligns with BASF's strategy of disciplined capital allocation.
How this was made
The 30-second read
Why it matters
Ending the pursuit removes a near-term M&A catalyst and highlights BASF’s valuation discipline, which can shift investor focus back to organic growth and shareholder distributions.
Market read
Traders may adjust BASF’s deal probability assumptions and any relative-value positioning tied to European chemicals consolidation.
What to watch
The article does not disclose the full terms of the rejected proposals or Evonik’s counter-position, so the market may overreact without knowing whether a revised offer could still emerge.
Background
BASF pursued a proposed combination with Evonik after indicating willingness to consider a moderate increase, but said it received no meaningful engagement from Evonik’s Executive Board.
Ticker impact
BASF ended its Evonik takeover effort after Evonik rejected two non-binding, all-cash offers, citing valuation limits and risk concerns.
Shares may face mild downside or volatility as the market re-prices the abandoned combination and any deal-related synergy hopes.
The article is a first-order corporate development that removes a potential catalyst, but it does not provide deal economics beyond the stated 24 euros per share and lacks Evonik’s response.
Market effects
Signals disciplined M&A posture in specialty chemicals, potentially lowering deal-premium expectations across European chemical peers.
European industrials and chemicals sentiment may soften on reduced consolidation odds.
Limited direct global spillover, but it can affect cross-border chemical M&A sentiment.
Counterpoint
BASF’s withdrawal could be interpreted as a valuation reset that preserves optionality for a later, better-structured bid if Evonik’s standalone outlook deteriorates.
Key entities
- companyBASF SE
Specialty chemicals company that withdrew from acquiring Evonik after two rejected non-binding all-cash offers.
- companyEvonik Industries AG
Specialty chemicals company that rejected BASF’s non-binding all-cash offers and did not provide disclosed response in the article.


